Data Safety Monitoring Boards Facilitate Ethical Research
In clinical trials, the safety of research participants is paramount. An organization conducting or sponsoring clinical research can ensure participant
In clinical trials, the safety of research participants is paramount. An organization conducting or sponsoring clinical research can ensure participant
With MCA processes slowing trial activation, AACI suggests sponsors play an active role in MCA preparation to reduce budget and startup delays.
The study startup process is a critical point in research, and oftentimes, can make or break a study’s success.
Clinical research aims to produce knowledge in the service of treating diseases and improving human health. In a just and
IVDs diagnose and monitor health using biospecimens, often in labs. FDA-regulated but varied in compliance, IVDs require careful IRB review preparation.
The use of engineered genetic materials in clinical trials is rapidly expanding, with potential applications for genetic vaccines, gene-modified cellular
The Food and Drug Administration’s (FDA’s) proposed single institutional review board (sIRB) mandates are in part designed to support greater
The Food and Drug Administration (FDA) recently released new guidance regarding cellular and gene therapy products, one of which may
Metrics in general are one of the ways we can gauge how well a program or service delivers. In the
New privacy regulations seem to form every few months, especially with individual U.S. states adopting their own privacy regulations (e.g.,
As clinical trial efficiencies grow, understanding single IRB mandates becomes crucial for sites and sponsors navigating ethical review processes.
The research informed consent form (ICF) is designed to provide prospective participants with the necessary information to make an informed